UBS analyst Dan Leonard lowered the firm’s price target on Agilent (A) to $130 from $150 and keeps a Neutral rating on the shares. Agilent maintained its outlook despite the “dynamic” macro environment, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Agilent’s Strong Performance and Promising Outlook: A Buy Recommendation by Daniel Arias
- Agilent price target lowered to $155 from $160 at JPMorgan
- Agilent’s Strong Financial Performance and Strategic Growth Initiatives Support Buy Rating with $155 Price Target by 2025
- Agilent’s Strong Q2 Performance Balanced by Tariff Risks and Market Uncertainties: Hold Rating Maintained
- Agilent’s Balanced Outlook: Hold Rating Amid Tariff Challenges and Future Margin Improvements